Comprehensive genomic characterization defines human glioblastoma genes and core pathways Cancer Genome Atlas Research Network Tissue source sites: Duke University ... Nature 455 (7216), 1061-1068, 2008 | 7331 | 2008 |
Gene essentiality and synthetic lethality in haploid human cells VA Blomen, P Májek, LT Jae, JW Bigenzahn, J Nieuwenhuis, J Staring, ... Science 350 (6264), 1092-1096, 2015 | 861 | 2015 |
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV A Stukalov, V Girault, V Grass, O Karayel, V Bergant, C Urban, DA Haas, ... Nature 594 (7862), 246-252, 2021 | 587 | 2021 |
Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy KVM Huber, E Salah, B Radic, M Gridling, JM Elkins, A Stukalov, ... Nature 508 (7495), 222-227, 2014 | 437 | 2014 |
Artemisinins target GABAA receptor signaling and impair α cell identity J Li, T Casteels, T Frogne, C Ingvorsen, C Honore, M Courtney, ... Cell 168 (1), 86-100. e15, 2017 | 382 | 2017 |
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia F Grebien, M Vedadi, M Getlik, R Giambruno, A Grover, R Avellino, ... Nature chemical biology 11 (8), 571-578, 2015 | 280 | 2015 |
Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS M Varjosalo, R Sacco, A Stukalov, A Van Drogen, M Planyavsky, S Hauri, ... Nature methods 10 (4), 307-314, 2013 | 229 | 2013 |
A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis A Fauster, M Rebsamen, KVM Huber, JW Bigenzahn, A Stukalov, ... Cell death & disease 6 (5), e1767-e1767, 2015 | 193 | 2015 |
Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing S Sadegh, J Matschinske, DB Blumenthal, G Galindez, T Kacprowski, ... Nature communications 11 (1), 3518, 2020 | 167 | 2020 |
Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action MV Babak, SM Meier, KVM Huber, J Reynisson, AA Legin, MA Jakupec, ... Chemical science 6 (4), 2449-2456, 2015 | 153 | 2015 |
An orthogonal proteomic survey uncovers novel Zika virus host factors P Scaturro, A Stukalov, DA Haas, M Cortese, K Draganova, A Płaszczyca, ... Nature 561 (7722), 253-257, 2018 | 151 | 2018 |
A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape P Hubel, C Urban, V Bergant, WM Schneider, B Knauer, A Stukalov, ... Nature immunology 20 (4), 493-502, 2019 | 148 | 2019 |
Functional dissection of the TBK1 molecular network A Goncalves, T Bürckstümmer, E Dixit, R Scheicher, MW Gorna, E Karayel, ... PloS one 6 (9), e23971, 2011 | 134 | 2011 |
Imprinted Igf2r silencing depends on continuous Airn lncRNA expression and is not restricted to a developmental window F Santoro, D Mayer, RM Klement, KE Warczok, A Stukalov, DP Barlow, ... Development 140 (6), 1184-1195, 2013 | 102 | 2013 |
Clinical significance of genetic aberrations in secondary acute myeloid leukemia JD Milosevic, A Puda, L Malcovati, T Berg, M Hofbauer, A Stukalov, ... American journal of hematology 87 (11), 1010-1016, 2012 | 100 | 2012 |
Germline RBBP6 mutations in familial myeloproliferative neoplasms AS Harutyunyan, R Giambruno, C Krendl, A Stukalov, T Klampfl, T Berg, ... Blood, The Journal of the American Society of Hematology 127 (3), 362-365, 2016 | 63 | 2016 |
The RNA‐binding protein HuR/ELAVL1 regulates IFN‐β mRNA abundance and the type I IFN response B Herdy, T Karonitsch, GI Vladimer, CSH Tan, A Stukalov, C Trefzer, ... European journal of immunology 45 (5), 1500-1511, 2015 | 57 | 2015 |
Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms J Li, K Bennett, A Stukalov, B Fang, G Zhang, T Yoshida, I Okamoto, ... Molecular systems biology 9 (1), 705, 2013 | 53 | 2013 |
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity A Skucha, J Ebner, J Schmöllerl, M Roth, T Eder, A César-Razquin, ... Nature Communications 9 (1), 1983, 2018 | 52 | 2018 |
Blackboxoptim. jl R Feldt, A Stukalov See https://github. com/robertfeldt/BlackBoxOptim. jl, 2018 | 49 | 2018 |